A subset of patients (2–3%) with a combined syndrome of juvenile polyposis and HHT (defined as JPHT) harbor mutations in the MADH4 (SMAD4) gene (Gallione et al., 2004). Here, SMAD4 is linked to juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome.